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The process of cell differentiation in Friend-erythroleukemia cells was accompanied by 80-90% inhibition 
of ~53 synthesis. This decrease was found to be linked to changes in cell-cycle distribution characteristics 
of the growth arrest program during differentiation rather than to the induction of the globin genes. The 
shut-off in the expression of ~53 always preceded the specific arrest of cells in the Go/G, phase. Interferon 
did not modulate down the expression of ~53 if added to transformed non-induced Friend-erythroleukemia 
cells; however, it slightly enhanced the extent of reduction in p53 synthesis if added during cell 
differentiation, thus suggesting a differential effect of interferon between cells at different stages of 
differentiation 
Friend cell Differentiation ~53 Synthesis Cell cycle Interferon 
1. INTRODUCTION 
Many transformed cells express high levels of a 
cellular encoded phosphoprotein termed ~53. 
While ~53 was first described in Simian virus 40 
(SV40)-transformed cells [ 11, it has become clear 
that high levels of ~53 expression characterize cells 
which were transformed by a wide variety of 
agents 121. The ~53 was detected in normal cells in 
small amounts and it has been suggested that this 
protein might have a role in the regulation of the 
mammalian cell cycle 13-51. Friend-erythro- 
leukemia cells are virus-transformed erythroid cell 
precursors that can be induced by dimethylsul- 
foxide (Me2SO) and a variety of other agents to ex- 
press characteristics of terminal erythroid cell dif- 
ferentiation [6]. The induced differentiation is 
characterized by the coordinated expression of 
commitment to terminal division [7] and ac- 
* To whom correspondence should be addressed 
cumulation of the different globin mRNAs, the 
corresponding hemoglobins, and many other 
specific proteins. We here report that following in- 
duction of differentiation, the rate of ~53 synthesis 
preferentially decreases in correlation with the 
changes in cell cycle distribution. Interferon, 
which is considered a cellular growth inhibitor 
[8,9] does not modulate down the expression of 
~53 if added to transformed non-induced 
Friend-er~hroleukemia cells; however, it, further 
reduces the minimal levels of ~53 synthesis in dif- 
ferentiating cells. 
2. MATERIALS AND METHODS 
The Friend-erythroleukemia cells used originate 
from clone 745 [lo], and were grown as in [l 11. 
Cell density was determined by a model D Coulter 
counter. 
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2.2. Induction of differentiation 
Exponentially growing Friend-erythroleukemia 
cells were inoculated at a density of 10’ cells/ml, 
and 1.5% (v/v) dimethylsulfoxide (Me2SO) was 
added (time 0). Three days later, the culture was 
diluted lo-fold into fresh medium supplemented 
with 1.5% MezSO in order to prevent the differ- 
entiating cells from reaching saturation cell den- 
sities [ 111. When indicated, cells were induced with 
MezSO at lo4 cells/ml and the dilution step on day 
3 was omitted. Hemoglobin content in cell extracts 
was measured by the benzidine assay as in [ 111. 
were obtained from E. Harlow (ICRF, London) 
[ 121, and concentrated by ammonium sulfate pre- 
cipitation. Mouse P interferon was prepared from 
Friend-erythroleukemia cells as in [ 111. 
3. RESULTS 
3.1. Decrease in the synthesis and stability of p53 
protein during differentiation of Friend-eryth- 
roleukemia cells 
2.3. Cell-labeling and immunoprecipitation 
106-lo7 cells were pulse-labeled for 20 min with 
[35S]methionine (50 &i/ml, 1200 Ci/mmol) in 
methionine-lacking Dulbecco’s modified Eagle’s 
medium containing 2% dialyzed fetal calf serum. 
Cells were washed with phosphate-buffered saline 
at 4°C and the pellet was extracted in lysis buffer 
(10 mM NaH2POJNa2HP04, pH 7.5/100 mM 
NaCl/l% Triton X-100/0.5% sodium deoxychol- 
ate/O. 1% NaDodS04) containing protease in- 
hibitors, and clarified for 10 min at 100000 x g. 
Fractions of cell lysate (0.1-0.5 ml) containing lo7 
trichloroacetic acid precipitable cpm were pre- 
absorbed with Staphylococcus aureus (formaline 
fixed) and immunoprecipitated with monoclonal 
antibodies to ~53 (18 h in 4°C). Antigen-antibody 
complexes were collected following binding to S. 
aureus (1 h in 4”C), then extensively washed with 
lysis buffer, processed and run on 10% NaDodS04 
polyacrylamide gels. The intensity of the ~53 band, 
from autoradiograms prepared following fluoro- 
graphy of the gels, was measured with Cliniscan 
scanner and the peak area was calculated. 
Friend-erytrholeukemia cells were labeled for 
20 min with [35S]methionine during the exponen- 
tial growth phase (2 x lo6 cells/ml) and the ~53 
was isolated by immunoprecipitation with 
monoclonal antibodies against his protein. Fig. IA 
shows that the erythroleukemia cells expressed 
relatively high amounts of ~53 which comigrated 
on SDS-polyacrylamide gels with the ~53 of the 
Abelson murine leukemia virus-transformed lym- 
phocytes [ 131. Following exposure of these cells to 
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2.4. Cytojluorometry analysis 
Samples of IO6 cells were stained with propidium 
iodide (50 pg/ml; Sigma) in the presence of 0.1% 
Triton X-100 and 4 x lo4 cells were analyzed in a 
fluorescence activated cell sorter (model FACS II 
Becton-Dickinson). The fluorescent signals were 
detected with S-11 photomultiplier tube set at 
550 V. The percentage of cells in the different 
phases of the cell-cycle was calculated from the 
DNA content distribution of cells. 
2.5. Materials 
Fig.1. p53 synthesis during differentiation of Friend- 
erythroleukemia cells (A) Exponentially growing cells 
(2 x lo6 cells/ml) were pulse-labeled for 20 min with 
[35S]methionine, qual amounts (10’ cpm) of trichloro- 
acetic acid-insoluble radioactivity were immunoprecipi- 
tated with monoclonal antibodies to pS3 and analyzed 
on SDS-polyacrylamide gels, as described in section 2. 
Lane 1, Friend-erythroleukemia cells; lane 2, Abelson 
murine leukemia virus-transformed lymphocytes. (B) 
Friend-erythroleukemia cells were induced to differen- 
tiate at lo5 cells/ml as described in section 2. At different 
time intervals samples were pulse-labeled, and 10’ tri- 
chloroacetic acid-immunoprecipitated as in (A). Lanes 
1-5, days 0, 1, 2, 4 and 7, respectively; lane 6, immuno- 
precipitation as in lane 1 with normal mouse serum 
instead of antibodies to ~53. M,-marker proteins are 
Monoclonal antibodies against ~53 (PAb 421) shown between (A) and (B). 
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the inducer of differentiation (MezSO), the rate of 
~53 synthesis gradually decreased reaching 
minimal levels at day 7 post-induction (fig.lB). 
The extent of reduction in the rate of ~53 synthesis 
during cell differentiation varied within a range of 
5-lo-fold in the different experiments. It should be 
noted that under the specific conditions of Me2SO 
induction performed in this experiment, cell densi- 
ty varied between lo5 and 2 x IO6 cells/ml [I 11. 
However, this parameter by itself, in the absence 
of Me2S0, did not influence the rate of ~53 syn- 
thesis (lane 1, fig. lA,B). 
The half-line of p53 protein before and after in- 
duction of differentiation was determined by pulse 
chase experiments as described in fig.2. In non- 
induced cells, the half-life of p53 was about 3.5 h 
and it decreased about 3-fold in the terminally dif- 
ferentiated cells as calculated from the slopes of 
the curves. 
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Fig.2. Pulse chase analysis of p53 in control non-induced 
and MezSO-induced Friend cells. Exponentially growing 
control cells ( lo6 cells/ml) and differentiated cells at day 
7 post-induction (2 x lo6 cells/ml) were pulse-labeled as 
in fig.1. At the end of the pulse, the cells were washed 
extensively with methionine containing medium free of 
the radioisotope and incubated in the same medium for 
the indicated chase periods. Equal amounts of trichloro- 
acetic acid-insoluble radioactivity were immunoprecipi- 
tated, analyzed on gels and the autoradiograms canned 
as in section 2. Levels of the ~53 are expressed as a 
percentage of the corresponding 0 h chase sample. 
(M) control cells; (C--O) differentiated cells. Insert: 
lanes l-5, samples from differentiated cells at 0-, l-, 
1.5-, 3.25- and 6-h chase periods, respectively; lanes 
7-10, samples from control cells at 0-, l-, 3- and 6.5-h 
chase periods, respectively; lane 6, M, marker proteins 
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Fig.3. Changes in cell-cycle distribution during differen- 
tiation of Friend-erythroleukemia cells. Cells were in- 
duced by 1.5% Me2SO at IO5 cells/ml and samples were 
removed for cytofluorometric analysis at different days 
following induction as in section 2. The percentage of 
cells found at the S + Ci2 + M phases of the cell-cycle 
was calculated from the DNA distribution profile of 
cells; two of them are illustrated in the insert (days 1 and 
7 of differentiation). The first peak represents the 
number of cells with Go/G] DNA content, the second 
peak presents cells with C&M DNA content, and between 
as in fig.1. the two peaks are represented cells in the S stage. 
3.2. Reduction in the rate of ~53 synthesis is cor- 
related with the commitment o terminal cell 
division during the process of differentiation 
We have here determined the distribution of 
cells within the different phases of the cell-cycle by 
cytofluorometric analysis of DNA content of the 
cells. Fig.3 shows that in exponentially growing 
cells (time 0), 65% of cells were found at the 
replicative phases of the cell cycle, i.e., S + G2 + M 
phases, and this value gradually decreased follow- 
ing induction of differentiation. It can therefore be 
concluded that the typical decline in the rate of cell 
growth reported to take during differentiation [ 1 l] 
results from specific accumulation of cells at the 
resting phase of the cell cycle; i.e., the Go/G, 
phase. In this respect, it was of interest to deter- 
mine whether the reduction in ~53 synthesis is 
preferentially linked to this defined program of 
growth arrest rather than to the other pathways 
which operate during cell differentiation. Fig.4. 
shows that exposure of cells to Me2SO at low cell 
density (lo4 cells/ml) delayed the changes in cell- 
cycle distribution by 24 h as compared to the con- 
ventional induction at 10’ cells/ml. whereas the 
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Fig.4. Kinetics of the changes in cell-cycle distribution, 
~53 synthesis and hemoglobin accumulation following 
MezSO induction at low cell density; comparison with 
the conventional conditions of differentiation. Friend 
cells were induced by 1.5% MezSO at 104 cells/ml (0) 
and 10’ cells/ml (w) as described in section 2. At dif- 
ferent time intervals, samples were pulse-labeled with 
[25S]methionine and the rate of ~53 synthesis was deter- 
mined by densitometric tracing of the autoradiogram as 
in section 2. Another portion of cells was used for 
cytofluorometric analysis as in fig.3. Hemoglobin was 
determined in 20pg cell extract. ( -) Rate of ~53 
synthesis expressed in arbitrary units; (-----) percen- 
tage of cells found at replicative phases S + G2 + M; 
(- - - - -) hemoglobin total proteins (To). 
kinetics of hemoglobin accumulation were not 
changed. Very interestingly, the decrease in the 
rate of ~53 synthesis also depended on cell concen- 
tration and a similar delay of 24 h was detected in 
the kinetics of reduction in ~53 synthesis if induc- 
tion started at a low cell density (fig.4). The decline 
in the expression of ~53 during cell differentiation 
seems, therefore, to be linked to the program of 
growth arrest rather than to the induction of the 
globin genes. Fig.4 also shows that in both condi- 
tions of induction of differentiation the reduction 
in the rate of ~53 always preceded this specific 
change in cell-cycle distribution. 
3.3. Effects of interferon on cell growth and on the 
expression of ~53 in Friend-erythroleukemia 
cells 
We have exposed Friend-erythroleukemia cells 
to interferon in order to study whether interferon 
changes the expression of ~53 protein under condi- 
tions where it inhibits cell growth. Table 1 shows 
that the treatment of transformed non-induced 
cells with 1000 Units/ml of interferon resulted in 
growth inhibition without affecting either the rate 
of ~53 synthesis or the distribution of cells within 
the different phases of the cell cycle. The response 
of differentiating Friend-erythroleukemia cells to 
interferon was, however, completely different. 
MezSO-induced cells were lOO-times more sensitive 
to the antigrowth effect of interferon than non- 
induced cells and 10 Units/ml were sufficient to 
cause 50% growth inhibition. In addition, low 
doses of interferon further reduced the minimal 
levels of ~53 synthesis measured at the end of the 
in vitro process of cell differentiation by 30070, and 
Table 1 
Effect of interferon on cell growth, cell-cycle distribution and the rate of ~53 synthesis in 
Friend-erythroleukemia cells 
Differentiating cells Non-induced cells 
IFN (units/ml)’ 1 10 10 1000 
Growth inhibition (Yo)~ 
Decrease in the ratio 
S + G2 + M/G1 phases (070) 
Inhibition of ~53 synthesis (070) 
25 50 none 
35 53 none 
32 35 none 
45 
none 
none 
a Interferon was added either to differentiating cells at day 4 post Me2SO induction or to exponen- 
tially growing non-induced cells. The different parameters were measured 72 h later, except for ~53 
synthesis which was determined 48 h after exposure to interferon. The data are expressed as percen- 
tage inhibition of the values measured in the corresponding cells not treated with interferon 
bGrowth was determined by monitoring cell density as in section 2 
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also reduced the portion of cells found at the 
replicative phases at that time (table 1). 
4. DISCUSSION 
We here report that the process of cell differen- 
tiation in Friend-erythroleukemia cells is accom- 
panied by SO-90% inhibition of ~53 synthesis. The 
change in the turnover of the ~53 protein is, 
however, less dramatic and the half-line decreases 
from 3.5 h in non-induced cells to about 1 h in ter- 
minally differentiated cells. Based on these two 
observations, we suggest hat a marked decline in 
the intracellular level of ~53 takes place during cell 
differentiation. Several mechanisms which regu- 
late the levels of ~53 in different cell systems were 
previously described, such as stabilization of ~53 
protein in SV40-transformed cells by its associa- 
tion with large T-antigen [l], or changes in the 
amount of translatable ~53 mRNA following dif- 
ferentiation of embryonal carcinoma cells [ 141. It 
will be of interest of study in the Friend cells 
whether transcriptional and/or post-trans~riptio- 
na1 events are being subjected to shut-off mechan- 
isms during differentiation, an approach which 
can be studied by using the p.53 cDNA clones 
which were recently isolated [ 151. 
It has been previously suggested that ~53 is in- 
volved in the regulation of the mammalian cell- 
cycle based on experiments performed on 
Go-arrested lymphocytes [2], normal kidney epi- 
thelium cells [3] and Swiss 3T3 cells 141. In the lat- 
ter case, microinjection of antibodies directed 
against ~53 into the nuclei of quiescent 3T3 cells 
inhibited their entry into the S phase of the cell cy- 
cle. According to the detailed kinetics presented 
here, reduction in ~53 synthesis starts at a short- 
time interval following Me2SO induction and 
precedes the typical arrest in growth which is 
characterized by accumulation of cells at the 
Go/G1 phase of the cell cycle. We here show that 
these two events are closely linked and it remains 
to be determined whether causal relationships exist 
between the decline in ~53 levels and the specific 
cell-cycle arrest. Variants of erythroleukemia cells 
inducible for homoglobin synthesis without com- 
mitment to terminal cell division have been recent- 
ly isolated 1161, and it will be of interest to test 
whether the shut-off mechanism of ~53 synthesis is 
operating in these cells. 
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Another feature which characterizes the shut-off 
in ~53 synthesis following Me$SO induction is its 
dependence on cell concentration. Starting induc- 
tion at cell density which was lo-times lower than 
the conventional conditions of induction delayed 
the kinetics of decline in ~53 synthesis by 24 h 
(time period which allows 2.3 cell doublings). One 
possibility to interpret these data is to assume that, 
unlike the induction of the globin genes, the shut- 
off in ~53 synthesis is not directly induced by 
Me,$O, but is rather modulated by extracellular 
factors secreted by the differentiating cells which 
have to reach certain threshold levels in order to be 
effective. We have previously reported that 
Friend-erythroleukemia cells secrete interferon 
during differentiation [ 111. However, since this 
interferon is produced at a late stage following in- 
duction (days 5-7) and the addition of neutralizing 
antibodies against this specific interferon did not 
affect the rate of ~53 synthesis (not shown), it is 
unlikely that the spontaneous interferon could 
modulate the main reduction of ~53 synthesis. In 
addition, the data in this work clearly demonstrate 
that exogenous preparations of interferon do not 
modulate down the expression of ~53 in trans- 
formed non-induced cells even if added at high 
doses which inhibit cell growth but can, however, 
further reduce the minimal levels of ~53 synthesis 
taking place during differentiation. It would be of 
interest to study in the future whether other 
negative growth factors besides interferon are be- 
ing secreted in these systems of cell differentiation. 
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